Net loss for the Group of €11.1 million in 2020, an improvement of €1.6 million compared to 2019. Gross cash position of €15.2 million as of 15 March 2021. …
Net loss for the Group of €12.7m in 2019, an improvement of €0.9m compared to 2018 Cash position of €16.6 million at 31 December 2019 Ms. Corinne Granger joins the…
Evry (France), 17 October 2019 – Publication of half-year financial statements as at 30 June 2019, audited and adopted by the Board of Directors at today’s meeting. The report for…
Evry (France) – 26 July 2019 – Global Bioenergies (Alternext Paris: ALGBE) presents the half-year report on the liquidity contract entrusted to the brokerage firm Gilbert Dupont. The following assets…
Evry (France), 25 July 2019 – Global Bioenergies has announced that it will hold a shareholder’s meeting on 5 September 2019 at 3pm at its offices located at 5, rue…
Evry (France), on 26 June 2019 Global Bioenergies (the “Company“) announces today having successfully closed its capital increase, launched on 20 June 2019 and conducted through a public offer without…
Participate Capital increase without preferential subscription rights and without priority subscription period through a public offer of an initial amount of €17 million, that may be increased up to €5…
Net loss for the Group of €13.6m in 2018, of which €2.9m in amortisation of the demo plant Cash position of €10.3m at 31 December 2018 Evry (France), 1…
Evry (France) – 25 January 2019 – Global Bioenergies (Euronext Growth : ALGBE) presents the full-year report on the liquidity contract entrusted to the brokerage firm Gilbert Dupont. The following assets appeared…
New York (United States) and Evry (France) October 24th, 2018 – Global Bioenergies (Euronext Growth: ALGBE) a leader in industrial biotechnology developing a process to convert renewable resources into hydrocarbons…